Literature DB >> 22001530

PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Igor Gurevich1, Carmen Zhang, Priscilla C Encarnacao, Charles P Struzynski, Sarah E Livings, Brian J Aneskievich.   

Abstract

Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFα-induced signaling through its interaction with NF-κB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR). The wide tissue distribution of TNIP1 provides the opportunity to influence numerous cellular responses in these roles and defining control of TNIP1 expression would be central to improved understanding of its impact on cell function. We cloned 6kb of the human TNIP1 promoter and performed predictive and functional analyses to identify regulatory elements. The promoter region proximal to the transcription start site is GC-rich without a recognizable TATA box. In contrast to this proximal ~500bp region, 6kb of the promoter increased reporter construct constitutive activity over five-fold. Throughout the 6kb length, in silico analysis identified several potential binding sites for both constitutive and inducible transcription factors; among the latter were candidate NF-κB binding sequences and peroxisome proliferator response elements (PPREs). We tested NF-κB and PPAR regulation of the endogenous TNIP1 gene and cloned promoter by expression studies, electrophoretic mobility shift assays, and chromatin immunoprecipitations. We validated NF-κB sites in the TNIP1 promoter proximal and distal regions as well as one PPRE in the distal region. The ultimate control of the TNIP1 promoter is likely to be a combination of constitutive transcription factors and those subject to activation such as NF-κB and PPAR.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001530      PMCID: PMC3249470          DOI: 10.1016/j.bbagrm.2011.09.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  76 in total

1.  NUBIScan, an in silico approach for prediction of nuclear receptor response elements.

Authors:  Michael Podvinec; Michel R Kaufmann; Christoph Handschin; Urs A Meyer
Journal:  Mol Endocrinol       Date:  2002-06

Review 2.  PPARs in diseases: control mechanisms of inflammation.

Authors:  Radina Kostadinova; Walter Wahli; Liliane Michalik
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation.

Authors:  S Hauser; G Adelmant; P Sarraf; H M Wright; E Mueller; B M Spiegelman
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

4.  A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

Authors:  Jérôme Eeckhoute; Jason S Carroll; Timothy R Geistlinger; Maria I Torres-Arzayus; Myles Brown
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

5.  Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.

Authors:  Hai-Lin Fang; Stephen C Strom; Hongbo Cai; Charles N Falany; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Mol Pharmacol       Date:  2005-01-05       Impact factor: 4.436

6.  The gene encoding the Acyl-CoA-binding protein is activated by peroxisome proliferator-activated receptor gamma through an intronic response element functionally conserved between humans and rodents.

Authors:  Torben Helledie; Lars Grøntved; Søren S Jensen; Pia Kiilerich; Luc Rietveld; Tatjana Albrektsen; Maria S Boysen; Jane Nøhr; Leif K Larsen; Jan Fleckner; Hendrik G Stunnenberg; Karsten Kristiansen; Susanne Mandrup
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

7.  Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.

Authors:  E Muñoz; G Courtois; P Veschambre; P Jalinot; A Israël
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 8.  Cross-talk between nuclear receptors and nuclear factor kappaB.

Authors:  K De Bosscher; W Vanden Berghe; G Haegeman
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

9.  All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs.

Authors:  B Durand; M Saunders; P Leroy; M Leid; P Chambon
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

10.  High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML.

Authors:  Manuel Favre; Christophe Butticaz; Brian Stevenson; C Victor Jongeneel; Amalio Telenti
Journal:  J Acquir Immune Defic Syndr       Date:  2003-10-01       Impact factor: 3.731

View more
  9 in total

Review 1.  Emerging roles for TNIP1 in regulating post-receptor signaling.

Authors:  Vincent P Ramirez; Igor Gurevich; Brian J Aneskievich
Journal:  Cytokine Growth Factor Rev       Date:  2012-04-28       Impact factor: 7.638

2.  Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Charles P Struzynsky; Sarah E Livings; Brian J Aneskievich
Journal:  Gene       Date:  2012-12-08       Impact factor: 3.688

3.  Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.

Authors:  Indra Adrianto; Shaofeng Wang; Graham B Wiley; Christopher J Lessard; Jennifer A Kelly; Adam J Adler; Stuart B Glenn; Adrienne H Williams; Julie T Ziegler; Mary E Comeau; Miranda C Marion; Benjamin E Wakeland; Chaoying Liang; Kenneth M Kaufman; Joel M Guthridge; Marta E Alarcón-Riquelme; Graciela S Alarcón; Juan-Manuel Anaya; Sang-Cheol Bae; Jae-Hoon Kim; Young Bin Joo; Susan A Boackle; Elizabeth E Brown; Michelle A Petri; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Lindsey A Criswell; Jeffrey C Edberg; Barry I Freedman; Gary S Gilkeson; Chaim O Jacob; Judith A James; Diane L Kamen; Robert P Kimberly; Javier Martín; Joan T Merrill; Timothy B Niewold; Bernardo A Pons-Estel; R Hal Scofield; Anne M Stevens; Betty P Tsao; Timothy J Vyse; Carl D Langefeld; John B Harley; Edward K Wakeland; Kathy L Moser; Courtney G Montgomery; Patrick M Gaffney
Journal:  Arthritis Rheum       Date:  2012-11

4.  TNF receptor-activated factor 2 mediates cardiac protection through noncanonical NF-κB signaling.

Authors:  Sarah Evans; Huei-Ping Tzeng; Deborah J Veis; Scot Matkovich; Carla Weinheimer; Attila Kovacs; Philip M Barger; Douglas L Mann
Journal:  JCI Insight       Date:  2018-02-08

5.  Association of a TNIP1 polymorphism with Vogt-Koyanagi-Harada syndrome but not with ocular Behcet's disease in Han Chinese.

Authors:  Yanyun Shi; Yading Jia; Shengping Hou; Jing Fang; Yan Zhou; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

6.  KLF6 depletion promotes NF-κB signaling in glioblastoma.

Authors:  A P Masilamani; R Ferrarese; E Kling; N K Thudi; H Kim; D M Scholtens; F Dai; M Hadler; T Unterkircher; L Platania; A Weyerbrock; M Prinz; G Y Gillespie; G R Harsh; M Bredel; M S Carro
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

Review 7.  TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling.

Authors:  Rambon Shamilov; Brian J Aneskievich
Journal:  J Immunol Res       Date:  2018-10-03       Impact factor: 4.818

8.  TNIP1 Regulates Cutibacterium acnes-Induced Innate Immune Functions in Epidermal Keratinocytes.

Authors:  Lilla Erdei; Beáta Szilvia Bolla; Renáta Bozó; Gábor Tax; Edit Urbán; Lajos Kemény; Kornélia Szabó
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

9.  Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.

Authors:  Lara Bossini-Castillo; Jose Ezequiel Martin; Jasper Broen; Carmen P Simeon; Lorenzo Beretta; Olga Y Gorlova; Madelon C Vonk; Norberto Ortego-Centeno; Gerard Espinosa; Patricia Carreira; Paloma García de la Peña; Natividad Oreiro; José Andrés Román-Ivorra; María Jesús Castillo; Miguel A González-Gay; Luis Sáez-Comet; Ivan Castellví; Annemie J Schuerwegh; Alexandre E Voskuyl; Anna-Maria Hoffmann-Vold; Roger Hesselstrand; Annika Nordin; Claudio Lunardi; Raffaella Scorza; Jacob M van Laar; Paul G Shiels; Ariane Herrick; Jane Worthington; Carmen Fonseca; Christopher Denton; Filemon K Tan; Frank C Arnett; Shervin Assassi; Bobby P Koeleman; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Ann Rheum Dis       Date:  2012-08-15       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.